Estrella Immunopharma Q3 EPS $(0.17) Misses $(0.08) Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Misses
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Estrella Immunopharma (NASDAQ:ESLA) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.08) by 112.5 percent. This is a 30.77 percent decrease over losses of $(0.13) per
Estrella Immunopharma (NASDAQ:ESLA) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.08) by 112.5 percent. This is a 30.77 percent decrease over losses of $(0.13) per share from the same period last year.
